{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:51:44Z","timestamp":1761058304911},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1989,2,1]],"date-time":"1989-02-01T00:00:00Z","timestamp":602294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J. Clin. Microbiol. Infect. Dis."],"published-print":{"date-parts":[[1989,2]]},"DOI":"10.1007\/bf01963893","type":"journal-article","created":{"date-parts":[[2005,7,29]],"date-time":"2005-07-29T06:39:37Z","timestamp":1122619177000},"page":"118-122","source":"Crossref","is-referenced-by-count":6,"title":["Neutropenia: Antibiotic combinations for empiric therapy"],"prefix":"10.1007","volume":"8","author":[{"given":"L. S.","family":"Young","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01963893_CR1","first-page":"467","volume-title":"The clinical approach to infection in the compromised host","author":"L. S. Young","year":"1988","unstructured":"Young, L. S.: Management of infections in leukemia and lymphoma. In: Rubin, R. H., Young, L. S. (ed.): The clinical approach to infection in the compromised host. Plenum Press, New York, 1988, p. 467\u2013524."},{"key":"BF01963893_CR2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","volume":"64","author":"G. P. Bodey","year":"1966","unstructured":"Bodey, G. P., Buckley, M., Sathe, Y. S., Freireich, E. J.: Quantitative relationships between circulating leukocytes and infections in patients with acute leukemia. Annals of Internal Medicine 1966, 64: 328\u2013340.","journal-title":"Annals of Internal Medicine"},{"key":"BF01963893_CR3","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archinte.1962.03620240038007","volume":"110","author":"W. R. McCabe","year":"1962","unstructured":"McCabe, W. R., Jackson, G. G.: Gram-negative bacteremia. II. Clinical, laboratory, and therapeutic observations. Archives of Internal Medicine 1962, 110: 856\u2013864.","journal-title":"Archives of Internal Medicine"},{"key":"BF01963893_CR4","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1001\/archinte.1968.03640050028006","volume":"121","author":"M. A. Freid","year":"1968","unstructured":"Freid, M. A., Vosti, K. L.: Importance of underlying disease in patients with gram-negative bacteremia. Archives of Internal Medicine 1968, 121: 418\u2013423.","journal-title":"Archives of Internal Medicine"},{"key":"BF01963893_CR5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1001\/archinte.1971.00310130124022","volume":"127","author":"R. E. Bryant","year":"1971","unstructured":"Bryant, R. E., Hood, A. F., Hood, C. E., Koenig, M. G.: Factors affecting mortality of gram-negative rod bacteremia. Archives of Internal Medicine 1971, 127: 120\u2013128.","journal-title":"Archives of Internal Medicine"},{"key":"BF01963893_CR6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0025-7125(16)32514-7","volume":"55","author":"D. Armstrong","year":"1971","unstructured":"Armstrong, D., Young, L. S., Meyer, R. D., Blevins, A.: Infectious complications of neoplastic disease. Medical Clinics of North America 1971, 55: 729\u2013745.","journal-title":"Medical Clinics of North America"},{"key":"BF01963893_CR7","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1001\/archinte.1985.00360090089015","volume":"145","author":"G. P. Bodey","year":"1985","unstructured":"Bodey, G. P., Jadeja, L., Elting, L.: Pseudomonas bacteremia: retrospective analysis of 410 episodes. Archives of Internal Medicine 1985, 145: 1621\u20131629.","journal-title":"Archives of Internal Medicine"},{"key":"BF01963893_CR8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000237759","volume":"24","author":"E. T. Anderson","year":"1978","unstructured":"Anderson, E. T., Young, L. S., Hewitt, W. L.: Antimicrobial synergism in the therapy of gram-negative rod bacteremia. Chemotherapy 1978, 24: 45\u201354.","journal-title":"Chemotherapy"},{"key":"BF01963893_CR9","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0002-9343(80)90243-0","volume":"68","author":"L. J. Love","year":"1980","unstructured":"Love, L. J., Schimpff, S. C., Schiffer, C. A., Wiernik, P. H.: Improved prognosis for granulocytopenic patients with gram-negative rod bacteremia. American Journal of Medicine 1980, 68: 643\u2013648.","journal-title":"American Journal of Medicine"},{"issue":"Supplement A","key":"BF01963893_CR10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jac\/8.suppl_A.121","volume":"8","author":"L. S. Young","year":"1981","unstructured":"Young, L. S., Meyer-Dudnik, D., Hindler, J., Martin, W. J.: Aminoglycosides in treatment of bacteremic infections in the immunocompromised host. Journal of Antimicrobial Chemistry 1981, 8 (Supplement A): 121\u2013132.","journal-title":"Journal of Antimicrobial Chemistry"},{"key":"BF01963893_CR11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1128\/AAC.29.2.263","volume":"29","author":"J. Klastersky","year":"1986","unstructured":"Klastersky, J., Glauser, M. P., Schimpff, S. C., Zinner, S. H., Gaya, H.: Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremia infection in febrile granulocytopenic patients. Antimicrobial Agents and Chemotherapy 1986, 29: 263\u2013270.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01963893_CR12","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1200\/JCO.1983.1.10.597","volume":"1","author":"International Antimicrobial Therapy Project Group of the European Organization for Research and Treatment of Cancer","year":"1983","unstructured":"International Antimicrobial Therapy Project Group of the European Organization for Research and Treatment of Cancer. Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. Journal of Clinical Oncology 1983, 1: 597\u2013603.","journal-title":"Journal of Clinical Oncology"},{"key":"BF01963893_CR13","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJM198608283150905","volume":"315","author":"P. A. Pizzo","year":"1986","unstructured":"Pizzo, P. A., Hathorn, J. W., Hiemenz, J., Brown, M., Commers, J., Cotton, D., Gress, J., Longo, D., Marshall, D., McKnight, J., Rubin, M., Skelton, J., Thaler, M., Wesley, R.: A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. New England Journal of Medicine 1986, 315: 552\u2013558.","journal-title":"New England Journal of Medicine"},{"key":"BF01963893_CR14","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJM198608283150910","volume":"315","author":"L. S. Young","year":"1986","unstructured":"Young, L. S.: Empirical antimicrobial therapy in the neutropenic host. New England Journal of Medicine 1986, 315: 580.","journal-title":"New England Journal of Medicine"},{"key":"BF01963893_CR15","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1056\/NEJM198712313172703","volume":"317","author":"EORTC Antimicrobial Therapy Project Group","year":"1987","unstructured":"EORTC Antimicrobial Therapy Project Group: Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. New England Journal of Medicine 1987, 317: 1692\u20131698.","journal-title":"New England Journal of Medicine"},{"key":"BF01963893_CR16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jac\/16.1.4","volume":"16","author":"L. S. Young","year":"1985","unstructured":"Young, L. S.: Double beta-lactam therapy in immuno-compromised host. Journal of Antimicrobial Chemotherapy 1985, 16: 4\u20136.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01963893_CR17","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0002-9343(84)90100-1","volume":"77","author":"D. J. Winston","year":"1984","unstructured":"Winston, D. J., Barnes, R. C., Ho W. G., Young, L. S., Champlin, R. E., Gale, R. P.: Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients. American Journal of Medicine 1984, 77: 442\u2013450.","journal-title":"American Journal of Medicine"},{"issue":"Supplement 8C","key":"BF01963893_CR18","first-page":"96","volume":"80","author":"C. A. Jongh de","year":"1986","unstructured":"de Jongh, C. A., Joshi, J. H., Newman, K. A., Moody, M. R., Wharton, R., Standiford, H. C., Schimpff, S. C.: Antibiotic synergism and response in gram-negative bacteremia in granulocytopenic cancer patients. American Journal of Medicine 1986, 80, Supplement 8C: 96\u2013111.","journal-title":"American Journal of Medicine"},{"key":"BF01963893_CR19","first-page":"177","volume-title":"Current clinical topics in infectious diseases","author":"L. S. Young","year":"1982","unstructured":"Young, L. S.: Combination or single drug therapy for gram-negative sepsis. In: Remington, J. S., Swartz, M. N. (ed.): Current clinical topics in infectious diseases. McGraw-Hill, New York, 1982, p. 177\u2013205."},{"key":"BF01963893_CR20","first-page":"109","volume":"67","author":"L. S. Young","year":"1983","unstructured":"Young, L. S.: Role of granulocyte transfusions in treating and preventing infection. Cancer Treatment Report 1983, 67: 109\u2013111.","journal-title":"Cancer Treatment Report"},{"key":"BF01963893_CR21","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM198804073181401","volume":"318","author":"S. J. Brandt","year":"1988","unstructured":"Brandt, S. J., Peters, W. P., Atwater, S. K., Kurtzberg, J., Borowitz, M. J., Jones, R. B., Shpall, E. J., Bast, R. C., Gilbert, C. J., Ortte, D. H.: Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. New England Journal of Medicine 1988, 318: 869\u2013876.","journal-title":"New England Journal of Medicine"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01963893.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01963893\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01963893","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T13:46:25Z","timestamp":1557755185000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01963893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1989,2]]}},"alternative-id":["BF01963893"],"URL":"https:\/\/doi.org\/10.1007\/bf01963893","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,2]]}}}